My aunt has breast cancer. Are there new clinical trials?

Question

Hello doctor,

As a science student and with my aunt's recent diagnosis of stage 2 breast cancer, I am eager to understand the latest advancements in cancer medications. Although she is currently undergoing medication and radiation therapy, I am particularly interested in learning more about the most promising clinical trials currently underway in oncology, especially those focusing on targeted therapies and immunotherapies.

Kindly answer these:

What are the most promising clinical trials currently underway in oncology?
How are targeted therapies and immunotherapies pushing the boundaries of traditional cancer treatment?
Could you explain the process of moving a potential cancer drug from the lab to clinical trials?
What are the biggest challenges researchers face in developing new oncology medicines?
Are there any groundbreaking approaches that might revolutionize cancer treatment in the near future?
How can aspiring researchers like me get involved in or stay updated on cutting-edge oncology research and clinical trials?

Kindly help.

Answer 1

Hello,

Welcome to icliniq.com.

I understand your concern.

To answer your question, below are the latest advancements in cancer medications:

1. Targeted therapies:

PARP Inhibitors: These are used in the treatment of breast and ovarian cancers with BRCA (breast cancer gene) mutations.
HER2-targeted therapies: New drugs targeting HER-2 positive breast cancer, such as Trastuzumab deruxtecan, are undergoing trials to assess their effectiveness in patients resistant to other HER2 therapies.

Immunotherapies:

Drugs like Pembrolizumab and Nivolumab are being tested for their ability to enhance the immune system's response against cancer cells.
CAR T-cell therapy: This treatment involves modifying a patient's T cells to target cancer cells.
Combining immunotherapy with other treatments.

The process from lab to clinical trials:

Preclinical Research: Involves laboratory and animal studies to test the safety and efficacy of a new drug.
Investigational new drug application: Researchers submit details of preclinical findings and propose a plan for human trials.

Clinical trials:

Phase I: Tests safety and dosage in a small group of volunteers.
Phase II: Expand the study to more patients to assess efficacy and side effects.
Phase III: Involves a larger patient population to confirm effectiveness, monitor side effects, and compare with standard treatments.
Phase IV: Post-marketing studies to gather additional information on the drug's risks, benefits, and optimal use.

Challenges in developing new oncology Medicines:

Complexity of Cancer Biology.
Drug Resistance.
High costs and long development Time.
Regulatory hurdles

Personalized medicine: Developing treatments based on individual genetic profiles to improve efficacy and reduce side effects.

Liquid biopsies: These non-invasive tests detect cancer-related genetic mutations and other biomarkers from a blood sample, aiding early detection and monitoring treatment response.

Artificial Intelligence: AI is being used to analyze vast amounts of data to identify potential drug candidates and predict their efficacy.

Microbiome research: Studying the role of gut bacteria in cancer progression and treatment response, with the potential to develop microbiome-based therapies.

Pursue a career in oncology research:

Pursue degrees in relevant fields such as molecular biology, oncology, or pharmacology.
Engage in internships and lab work to gain hands-on experience.
Join research programs at universities and institutions known for their oncology research.
Become a member of well-renowned organizations or associations to access resources, conferences, and networking opportunities.

I hope this information helps you, and please reach out if you have any doubts.

Thank you.